Staphylococcus is a genus of Gram-positive cocci that ranges from harmless skin commensals (the coagulase-negative staphylococci, or CoNS) to S. aureus, one of the most versatile human pathogens. Bench identification still hinges on Gram stain → catalase → coagulase, but rapid latex agglutination now collapses the final step to 20 seconds and detects MRSA in the same pass. Antimicrobial resistance — particularly methicillin and, increasingly, vancomycin-intermediate phenotypes — keeps S. aureus on every infection-prevention scorecard worldwide.
Key Facts
- Morphology: Gram-positive cocci, ~1 μm, arranged in irregular grape-like clusters.
- Catalase positive — the single test that separates Staphylococcus from Streptococcus.
- Coagulase positive = S. aureus (plus a few less-common species such as S. intermedius and S. lugdunensis).
- MRSA carries the mecA (or mecC) gene encoding PBP2a, conferring resistance to all standard beta-lactams.
- S. aureus carriage: ~30% of healthy adults are persistent or intermittent nasal carriers.
- Toxin diseases: staphylococcal food poisoning (heat-stable enterotoxins), toxic shock syndrome (TSST-1), and scalded skin syndrome (exfoliative toxins).
S. aureus vs. coagulase-negative staphylococci
The genus Staphylococcus contains more than 50 recognised species, but clinical microbiologists divide them functionally into two camps. Staphylococcus aureus is the species most strongly associated with disease — ranging from boils and impetigo to necrotising pneumonia, septic arthritis, osteomyelitis, infective endocarditis, and toxin-mediated syndromes. The other species, collectively known as coagulase-negative staphylococci (CoNS), include S. epidermidis, S. haemolyticus, S. saprophyticus, and S. lugdunensis. Most CoNS are skin commensals, but they are the leading cause of prosthetic-device infection — central-line bacteraemia, prosthetic-valve endocarditis, ventricular shunt infection, and prosthetic-joint infection — because of their ability to produce biofilm on polymer surfaces.
One CoNS species — S. lugdunensis — behaves clinically more like S. aureus, causing aggressive native-valve endocarditis. It can be misidentified because it possesses a bound clumping factor and gives a positive slide coagulase, although the tube coagulase is negative. Modern latex agglutination kits that incorporate multiple targets help disambiguate this in real time at the bench.
Virulence factors that matter
S. aureus succeeds clinically because of an unusually broad arsenal of secreted and surface-bound virulence factors. The most clinically relevant include:
- Coagulase — a secreted enzyme that binds prothrombin and clots fibrinogen, walling off the organism from phagocytes. It is the definitional virulence factor and the basis of the gold-standard tube test using rabbit coagulase plasma.
- Protein A — binds the Fc region of IgG, inverting antibody orientation on the bacterial surface and frustrating opsonophagocytosis. It is also one of the antigens detected by rapid latex kits.
- Clumping factor (ClfA/ClfB) — surface-bound fibrinogen-binding adhesins that mediate the rapid "slide coagulase" reaction.
- Pore-forming toxins — alpha-haemolysin, gamma-haemolysin, and the leukocidins, including Panton-Valentine leukocidin (PVL), the marker most strongly linked to community-associated MRSA skin and soft-tissue infection.
- Superantigens — TSST-1, the staphylococcal enterotoxins (SEA-SEE and related), and exfoliative toxins A and B, responsible for toxic shock, food poisoning, and scalded skin syndrome respectively.
- Capsular polysaccharide types 5 and 8 — antiphagocytic capsules carried by the majority of clinical isolates and the targets of several investigational vaccines.
The clinical syndromes
S. aureus disease can be grouped into three categories. The first is localised pyogenic infection — folliculitis, furuncles, carbuncles, impetigo, cellulitis, wound infection, mastitis, and abscess. The second is invasive infection — bacteraemia (with metastatic seeding to bone, joints, kidneys, lungs, and heart valves), pneumonia (often post-influenza), septic arthritis, and infective endocarditis. S. aureus bacteraemia carries a 90-day mortality of 20-30% in most high-income healthcare settings and is one of the few bloodstream infections for which formal infectious-diseases consultation has been shown to improve survival.
The third category is toxin-mediated disease. Staphylococcal food poisoning is one of the most common food-borne illnesses worldwide: the organism contaminates protein-rich food handled by a carrier, multiplies at room temperature, and releases heat-stable enterotoxins. Reheating kills the bacterium but does not inactivate the toxin — vomiting and diarrhoea begin 1-6 hours after ingestion and resolve within 24 hours. Toxic shock syndrome and staphylococcal scalded skin syndrome are rarer but life-threatening, and both can arise from a focal infection too small to detect clinically.
science Confirm at the Bench Prolex™ Staph Xtra Latex Kit — MRSA detection in 20 seconds Detects clumping factor, Protein A, capsular polysaccharide, and PBP2a from a single colony on solid media. CE marked, FDA 510(k) cleared. arrow_forwardThe bench identification workflow
The classical clinical-microbiology pathway to a confirmed S. aureus identification is unchanged in shape but dramatically faster in execution. After overnight growth on blood agar (golden or off-white colonies, often with a narrow zone of beta-haemolysis), the bench technologist runs three tests:
- Gram stain — Gram-positive cocci in clusters. Pro-Stains reagents (crystal violet, iodine, decoloriser, safranin) give the diagnostic morphology in under five minutes.
- Catalase test — a drop of 3% hydrogen peroxide on a colony. Vigorous bubbling = Staphylococcus; no bubbling = Streptococcus. (Run on a slide, not directly on a blood-agar colony, to avoid false positives from residual erythrocyte catalase.) An oxidase test is usually also performed in parallel for Gram-negative isolates on the same plate.
- Coagulase / latex agglutination — the species-defining step. Tube coagulase using rabbit plasma with EDTA remains the reference method (clot within 4 hours = positive; re-read at 24 hours). Latex agglutination collapses the same answer into 20 seconds.
Once an isolate is confirmed as S. aureus, the next clinically essential question is methicillin susceptibility. Modern combined latex kits include an MRSA reagent that detects PBP2a directly from cultured colonies after a brief induction step — giving the same answer that a cefoxitin disc or PCR would provide, but on the same workflow as the species ID itself. Confirmed isolates can then be archived on Microbank® cryopreservation beads for AMR surveillance, outbreak investigation, or repeat susceptibility testing.
AMR considerations
S. aureus is the canonical resistant Gram-positive pathogen. Methicillin resistance (MRSA) is now endemic in healthcare settings worldwide, although carriage and disease rates have fallen in several high-income countries over the past decade because of active surveillance, decolonisation, and hand hygiene programmes. Community-associated MRSA — usually USA300 in North America — remains a leading cause of skin and soft-tissue infection in young, otherwise healthy patients. Beyond methicillin, clinicians watch for vancomycin-intermediate (VISA), heterogeneous VISA (hVISA), and the very rare vancomycin-resistant (VRSA) phenotypes, as well as inducible clindamycin resistance (the D-test) and emerging linezolid resistance. Reliable bench identification is the first link in this chain: you cannot report a resistance pattern on an organism you have not first correctly named.
Frequently Asked Questions
What is the difference between S. aureus and coagulase-negative staphylococci?
S. aureus produces coagulase (which clots rabbit plasma) and is associated with skin, soft-tissue, bloodstream, bone, and toxin-mediated disease. CoNS such as S. epidermidis lack coagulase, are commonly skin commensals, and cause disease primarily in patients with implanted medical devices, prosthetic joints, or central lines.
What is MRSA?
MRSA is S. aureus carrying the mecA (or mecC) gene encoding PBP2a, an altered penicillin-binding protein conferring resistance to all standard beta-lactam antibiotics except newer agents such as ceftaroline. MRSA strains include hospital-associated (HA-MRSA), community-associated (CA-MRSA), and livestock-associated (LA-MRSA) lineages.
How is Staphylococcus aureus identified in the laboratory?
Gram stain (Gram-positive cocci in clusters) → catalase (positive separates Staphylococcus from Streptococcus) → coagulase, either tube coagulase using rabbit plasma or a rapid latex agglutination kit. Modern latex kits detect clumping factor, Protein A, capsular polysaccharide, and PBP2a (MRSA) simultaneously.
How fast is rapid latex agglutination for S. aureus?
Latex agglutination kits such as Prolex™ Staph Xtra give a visible result in 20 seconds from a single colony on solid media, compared with 4-24 hours for tube coagulase. The MRSA variant detects PBP2a directly from cultured colonies without requiring molecular methods.
Does S. aureus cause food poisoning?
Yes. S. aureus produces heat-stable enterotoxins (SEA through SEE and related variants). When food is contaminated by a carrier and held at room temperature, the organism multiplies and releases toxin. Reheating kills the bacterium but does not inactivate the toxin, which produces vomiting and diarrhoea within 1-6 hours of ingestion.
Are coagulase-negative staphylococci always contaminants?
No. CoNS are common skin flora and frequently contaminate blood cultures, but they are genuine pathogens in catheter-related bloodstream infection, prosthetic-valve endocarditis, prosthetic-joint infection, and neonatal bacteraemia. Clinical interpretation depends on the number of positive bottles, time-to-positivity, the patient's device status, and species (e.g., S. lugdunensis behaves more like S. aureus).
For technical questions about Staphylococcus identification at the bench, contact info@pro-lab.us, browse the Prolex™ Staph Xtra and Rabbit Coagulase Plasma product pages, or book a call with one of our scientists.